BackTelomir Pharmaceuticals Overview

Telomir Pharmaceuticals Current Assets

Track Telomir Pharmaceuticals's current assets ($5.4M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$5.37M
↑ 546.80% YoYΔ $4.54M vs prior year quarter

Peer trimmed avg / median

Loading

Telomir Pharmaceuticals Current Assets History

Loading

Telomir Pharmaceuticals vs. peers: Current Assets Comparison

Loading

Telomir Pharmaceuticals Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Telomir Pharmaceuticals (TELO) FAQ

Telomir Pharmaceuticals (TELO) currently reports a current assets of $5.4M as of June 2026. That compares with $830K in the prior-year period — up 546.8% year over year. Use the charts on this page to explore Telomir Pharmaceuticals's current assets history and peer comparisons.

Telomir Pharmaceuticals's current assets increased from $830K to $5.4M — a 546.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Telomir Pharmaceuticals reported $5.4M in current assets as of June 2026. That compares with $830K in the prior-year period — up 546.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $5.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Telomir Pharmaceuticals, and consider following TELO for alerts when major investors trade the stock.